These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Mucopolysaccharidoses I and II: Brief Review of Therapeutic Options and Supportive/Palliative Therapies. Nan H; Park C; Maeng S Biomed Res Int; 2020; 2020():2408402. PubMed ID: 33344633 [No Abstract] [Full Text] [Related]
3. Early enzyme replacement therapy enables a successful hematopoietic stem cell transplantation in mucopolysaccharidosis type IH: Divergent clinical outcomes in two Japanese siblings. Yamazaki N; Kosuga M; Kida K; Takei G; Fukuhara Y; Matsumoto H; Senda M; Honda A; Ishiguro A; Koike T; Yabe H; Okuyama T Brain Dev; 2019 Jun; 41(6):546-550. PubMed ID: 30755342 [TBL] [Abstract][Full Text] [Related]
4. Mucopolysaccharidosis type I. Wraith JE; Jones S Pediatr Endocrinol Rev; 2014 Sep; 12 Suppl 1():102-6. PubMed ID: 25345091 [TBL] [Abstract][Full Text] [Related]
5. Current and potential therapeutic strategies for mucopolysaccharidoses. Noh H; Lee JI J Clin Pharm Ther; 2014 Jun; 39(3):215-24. PubMed ID: 24612142 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic Options for Mucopolysaccharidosis II (Hunter Disease). Kubaski F; Vairo F; Baldo G; de Oliveira Poswar F; Corte AD; Giugliani R Curr Pharm Des; 2020; 26(40):5100-5109. PubMed ID: 33138761 [TBL] [Abstract][Full Text] [Related]
7. Enzyme replacement therapy and/or hematopoietic stem cell transplantation at diagnosis in patients with mucopolysaccharidosis type I: results of a European consensus procedure. de Ru MH; Boelens JJ; Das AM; Jones SA; van der Lee JH; Mahlaoui N; Mengel E; Offringa M; O'Meara A; Parini R; Rovelli A; Sykora KW; Valayannopoulos V; Vellodi A; Wynn RF; Wijburg FA Orphanet J Rare Dis; 2011 Aug; 6():55. PubMed ID: 21831279 [TBL] [Abstract][Full Text] [Related]
8. Laronidase for the treatment of mucopolysaccharidosis type I. Clarke LA Expert Rev Endocrinol Metab; 2011 Nov; 6(6):755-768. PubMed ID: 30780865 [TBL] [Abstract][Full Text] [Related]
9. A Cure for Sanfilippo Syndrome? A Summary of Current Therapeutic Approaches and their Promise. Pearse Y; Iacovino M Med Res Arch; 2020 Feb; 8(2):. PubMed ID: 32733997 [TBL] [Abstract][Full Text] [Related]
10. Open issues in Mucopolysaccharidosis type I-Hurler. Parini R; Deodato F; Di Rocco M; Lanino E; Locatelli F; Messina C; Rovelli A; Scarpa M Orphanet J Rare Dis; 2017 Jun; 12(1):112. PubMed ID: 28619065 [TBL] [Abstract][Full Text] [Related]
11. Bone Remodeling in an Mps-1h Girl after Hematopoietic Stem Cell Transplantation along with Enzymatic Replacement Therapy. Tummolo A; Brunetti G; Piacente L; Marzollo A; Biffi A; Burlina A; Faienza MF Endocr Metab Immune Disord Drug Targets; 2022; 22(14):1425-1432. PubMed ID: 35619307 [TBL] [Abstract][Full Text] [Related]
12. Gene therapy for lysosomal storage disorders: recent advances for metachromatic leukodystrophy and mucopolysaccaridosis I. Penati R; Fumagalli F; Calbi V; Bernardo ME; Aiuti A J Inherit Metab Dis; 2017 Jul; 40(4):543-554. PubMed ID: 28560469 [TBL] [Abstract][Full Text] [Related]
13. Enzyme replacement therapy (ERT) procedure for mucopolysaccharidosis type II (MPS II) by intraventricular administration (IVA) in murine MPS II. Higuchi T; Shimizu H; Fukuda T; Kawagoe S; Matsumoto J; Shimada Y; Kobayashi H; Ida H; Ohashi T; Morimoto H; Hirato T; Nishino K; Eto Y Mol Genet Metab; 2012 Sep; 107(1-2):122-8. PubMed ID: 22704483 [TBL] [Abstract][Full Text] [Related]
14. Sleep disordered breathing in mucopolysaccharidosis I: a multivariate analysis of patient, therapeutic and metabolic correlators modifying long term clinical outcome. Pal AR; Langereis EJ; Saif MA; Mercer J; Church HJ; Tylee KL; Wynn RF; Wijburg FA; Jones SA; Bruce IA; Bigger BW Orphanet J Rare Dis; 2015 Apr; 10():42. PubMed ID: 25887468 [TBL] [Abstract][Full Text] [Related]
15. The evolution of pulmonary function in childhood onset Mucopolysaccharidosis type I. Broomfield A; Sims J; Mercer J; Hensman P; Ghosh A; Tylee K; Stepien KM; Oldham A; Prathivadi Bhayankaram N; Wynn R; Wright NB; Jones SA; Wilkinson S Mol Genet Metab; 2021 Feb; 132(2):94-99. PubMed ID: 32713717 [TBL] [Abstract][Full Text] [Related]
16. Effects of neonatal enzyme replacement therapy and simvastatin treatment on cervical spine disease in mucopolysaccharidosis I dogs. Chiaro JA; O'Donnell P; Shore EM; Malhotra NR; Ponder KP; Haskins ME; Smith LJ J Bone Miner Res; 2014 Dec; 29(12):2610-7. PubMed ID: 24898323 [TBL] [Abstract][Full Text] [Related]